| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/05/1995 | WO1995000551A1 Prostaglandin receptor fp and dna encoding it |
| 01/05/1995 | WO1995000160A1 Programmed cell death genes and proteins |
| 01/05/1995 | WO1995000159A1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 01/05/1995 | WO1994026922A3 Methods and compositions relating to sterol regulatory element binding proteins |
| 01/05/1995 | WO1994025612A3 Nucleotide sequences for the control of the expression of dna sequences in a cellular host |
| 01/05/1995 | WO1994024164A3 Human monoclonal antibodies and processes and materials for making such antibodies |
| 01/05/1995 | WO1994018324A3 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide |
| 01/05/1995 | DE4405841C1 Multipotent non-specific immunity inducers based on combinations of poxvirus components, processes for their preparation and their use as pharmaceuticals |
| 01/05/1995 | CA2166124A1 Clostridium bifermentans dna fragment bearing genes coding for proteins linked to an insecticidal activity |
| 01/05/1995 | CA2165797A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 01/05/1995 | CA2165777A1 Programmed cell death genes and proteins |
| 01/05/1995 | CA2165559A1 Human cell adhesion protein aamp-1 and uses thereof |
| 01/05/1995 | CA2165461A1 Compositions and diagnostic methods using monoclonal antibodies against cd44v6 |
| 01/05/1995 | CA2164728A1 Processes for diagnosing and analysing tumours |
| 01/05/1995 | CA2162485A1 Toxin gene from xenorhabdus nematophilus |
| 01/05/1995 | CA2141535A1 Recombinant dnase b derived from streptococcus pyogenes |
| 01/04/1995 | EP0631731A1 Milk protein partial hydrolysate and process for preparation thereof |
| 01/04/1995 | EP0631631A1 A process for producing heme proteins |
| 01/04/1995 | EP0631629A1 Fungus-responsive chimaeric gene |
| 01/04/1995 | EP0631624A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 01/04/1995 | EP0631623A1 Dna encoding taurine and gaba transporters and uses thereof |
| 01/04/1995 | EP0631617A1 Colon crypt cell mitogen, cell line producing it, and uses thereof |
| 01/04/1995 | EP0631585A1 Protein production |
| 01/04/1995 | EP0631507A1 Selective alteration of antibody immunogenicity |
| 01/04/1995 | EP0631506A1 Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines |
| 01/04/1995 | EP0514405B1 Strain ral-4, useful for production of small proteins and peptides |
| 01/04/1995 | EP0463072B1 Novel insulin compounds |
| 01/04/1995 | CN1027288C Method for producing of PF1022 substance and anthelmintic composition containing same |
| 01/03/1995 | US5378823 Trophoblastin |
| 01/03/1995 | US5378819 Nucleic acid or DNA for genetic engineering |
| 01/03/1995 | US5378814 Hepatitis delta viral polypeptides |
| 01/03/1995 | US5378812 Human antibodies which specifically bind to lipopolysaccharide determinants of some pseudomonas serotypes and inhibit these bacteria, for prevention and treatment of infections |
| 01/03/1995 | US5378808 Isolated DNA sequence; anemia; genetic engineering |
| 01/03/1995 | US5378624 Methods for removing ligands from a particle surface |
| 01/03/1995 | US5378613 Method for increased expression of low molecular weight recombinant polypeptides |
| 01/03/1995 | US5378612 Nonionic surfactant, cyclodextrin |
| 01/03/1995 | US5378464 Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140 |
| 01/02/1995 | CA2127230A1 Methods and reagents for inhibiting cholesterol absorption in humans mediated by pancreatic cholesterol esterase |
| 12/31/1994 | CA2127068A1 Process for the preparation of native human glicentin |
| 12/28/1994 | EP0630411A1 Method for enzymatically synthesizing peptide alkyl esters, resulting products and use thereof |
| 12/28/1994 | EP0630405A1 Novel V28 seven transmembrane receptor |
| 12/28/1994 | EP0630401A1 Strain w micro-organism, enzyme compositions obtainable therefrom, use of the micro-organism and hydrolysis process especially of keratin. |
| 12/28/1994 | EP0630257A1 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 12/28/1994 | EP0413818B1 Process for producing a human neutrophil chemotactic factor polypeptide |
| 12/28/1994 | CN1096822A Improved methods for the preparation of endotoxinbinding proteins |
| 12/28/1994 | CN1096821A BPI-immunoglobulin fusion proteins |
| 12/28/1994 | CN1027179C Method of using bari for secreting foreign proteins |
| 12/27/1994 | US5376634 Microbiocides |
| 12/27/1994 | US5376546 Analogs of ribosome-inactivating proteins |
| 12/27/1994 | US5376536 Mutants |
| 12/27/1994 | US5376370 Vaccine for malaria |
| 12/27/1994 | US5376367 Fusion proteins comprising MGF and IL-3 |
| 12/22/1994 | WO1994029724A1 Anti-cd3 antibody-aminodextran conjugates for induction of t-cell activation and proliferation |
| 12/22/1994 | WO1994029478A1 Immunoassay reagents and methods for detecting brequinar and analogs |
| 12/22/1994 | WO1994029472A2 Mengovirus as a vector for expression of foreign polypeptides |
| 12/22/1994 | WO1994029471A1 Adenoviral vectors for treatment of hemophilia |
| 12/22/1994 | WO1994029463A1 Yeast promotor and use thereof |
| 12/22/1994 | WO1994029462A1 Multicistronic expression of recombinant genes in bacterial cells |
| 12/22/1994 | WO1994029459A1 Stress proteins and uses therefor |
| 12/22/1994 | WO1994029458A1 Hybrid receptor molecules |
| 12/22/1994 | WO1994029457A2 Process for producing fusion proteins comprising scfv fragments by a transformed mould |
| 12/22/1994 | WO1994029451A2 Humanised antibodies |
| 12/22/1994 | WO1994029449A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
| 12/22/1994 | WO1994029448A1 Dna and protein coded for thereby |
| 12/22/1994 | WO1994029447A2 Dna coding for the human thyrotropin-releasing hormone receptor |
| 12/22/1994 | WO1994029446A2 Intracellular binding proteins and use thereof |
| 12/22/1994 | WO1994029436A1 Methods for selectively stimulating proliferation of t cells |
| 12/22/1994 | WO1994029351A3 Antibodies |
| 12/22/1994 | WO1994029351A2 Antibodies |
| 12/22/1994 | WO1994029350A2 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 12/22/1994 | WO1994029348A2 Production of antibody fragments |
| 12/22/1994 | WO1994029347A1 Antibody fragments in therapy |
| 12/22/1994 | WO1994029346A1 IDENTIFICATION OF THE ADHESIN GENE FROM $i(M. PIRUM) |
| 12/22/1994 | WO1994029344A1 Super proteins including interferons and interleukins |
| 12/22/1994 | WO1994029343A1 CLONING AND USES OF THE GENETIC LOCUS bcl-6 |
| 12/22/1994 | WO1994029341A1 Methods of enhancing bioactivity of chemokines |
| 12/22/1994 | WO1994029333A1 Immunoreactive reagents employing monoamine oxidase |
| 12/22/1994 | WO1994029332A1 Coiled-coil stem loop templates |
| 12/22/1994 | WO1994029330A1 Myeloid cell leukemia associated gene mcl-1 |
| 12/22/1994 | WO1994029329A1 Haptens, tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids |
| 12/22/1994 | WO1994028931A1 Methods for treating inflammatory disorders |
| 12/22/1994 | WO1994025617A3 Monoclonal antibodies against ck-mb |
| 12/22/1994 | WO1994025606A3 Recombinant alanine racemase and gapdh from tolypocladium |
| 12/22/1994 | WO1994025596A3 Immunogenic formulation of ospc antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens |
| 12/22/1994 | WO1994021805A3 Method of controlling insects in plants |
| 12/22/1994 | WO1994020628A3 Improved feedcrops enriched in sulfur amino acids and methods for improvement |
| 12/22/1994 | WO1994016074A3 High molecular weight b-cell growth factor: interleukin-14 |
| 12/22/1994 | DE4401419C1 Secretion of proteins of the outer membrane of Gram-negative bacteria by means of Gram-positive host organisms |
| 12/22/1994 | CA2164864A1 Yeast promotor and use thereof |
| 12/22/1994 | CA2164811A1 Super proteins including interferons and interleukins |
| 12/22/1994 | CA2164646A1 Anti-cd3 antibody-aminodextran conjugates for induction of t-cell activation and proliferation |
| 12/22/1994 | CA2164623A1 Hybrid receptor molecules |
| 12/22/1994 | CA2164518A1 Immunoreactive reagents employing monoamine oxidase |
| 12/22/1994 | CA2164510A1 Immunoassay reagents and methods for detecting brequinar and analogs |
| 12/22/1994 | CA2164298A1 Stress proteins and uses therefor |
| 12/22/1994 | CA2164297A1 Mengovirus as a vector for expression of foreign polypeptides |
| 12/22/1994 | CA2163345A1 Antibodies |
| 12/22/1994 | CA2163344A1 Humanised antibodies |
| 12/22/1994 | CA2162878A1 Process for producing fusion proteins comprising scfv fragments by a transformed mould |
| 12/22/1994 | CA2162497A1 Adenoviral vectors for treatment of hemophilia |